🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $EXPN.L and executed a SELL strategy, securing a +27.05% net profit.

UPGRADE TO SEE LIVE SIGNALS

$BCAB

Bioatla Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 06, 2026 🌙 Close🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP1.12%
MAX GAP RECORD-13.49%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.8%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL